Literature DB >> 8616722

Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans.

M W Schwartz1, E Peskind, M Raskind, E J Boyko, D Porte.   

Abstract

The adipocyte hormone, leptin (OB protein), is proposed to be an "adiposity signal" that acts in the brain to lower food intake and adiposity. As plasma leptin levels are elevated in most overweight individuals, obesity may be associated with leptin resistance. To investigate the mechanisms underlying brain leptin uptake and to determine whether reduced uptake may contribute to leptin resistance, we measured immunoreactive leptin levels in plasma and cerebrospinal fluid (CSF) of 53 human subjects. Leptin concentrations in CSF were strongly correlated to the plasma level in a nonlinear manner (r = 0.92; p = 0.0001). Like levels in plasma, CSF leptin levels were correlated to body mass index (r = 0.43; p = 0.001), demonstrating that plasma leptin enters human cerebrospinal fluid in proportion to body adiposity. However, the efficiency of this uptake (measured as the CSF:plasma leptin ratio) was lower among those in the highest as compared with the lowest plasma leptin quintile (5.4-fold difference). We hypothesize that a saturable mechanism mediates CSF leptin transport, and that reduced efficiency of brain leptin delivery among obese individuals with high plasma leptin levels results in apparent leptin resistance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616722     DOI: 10.1038/nm0596-589

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  198 in total

Review 1.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 2.  Electrophysiological analysis of circuits controlling energy homeostasis.

Authors:  Masoud Ghamari-Langroudi
Journal:  Mol Neurobiol       Date:  2012-02-14       Impact factor: 5.590

Review 3.  Gut hormones: the future of obesity treatment?

Authors:  Anne K McGavigan; Kevin G Murphy
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

Review 4.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

Review 5.  Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

Authors:  Iason T Papademetriou; Tyrone Porter
Journal:  Ther Deliv       Date:  2015-08-25

6.  Selective inactivation of Socs3 in SF1 neurons improves glucose homeostasis without affecting body weight.

Authors:  Ren Zhang; Harveen Dhillon; Huali Yin; Akihiko Yoshimura; Bradford B Lowell; Eleftheria Maratos-Flier; Jeffrey S Flier
Journal:  Endocrinology       Date:  2008-07-31       Impact factor: 4.736

7.  Effects of seafood consumption and weight loss on fasting leptin and ghrelin concentrations in overweight and obese European young adults.

Authors:  Alfons Ramel; Dolores Parra; J Alfredo Martinéz; Mairead Kiely; Inga Thorsdottir
Journal:  Eur J Nutr       Date:  2009-01-13       Impact factor: 5.614

8.  Dynamic responses to leptin secretagogues in lean, obese, and massively obese men and women.

Authors:  Samuel Dagogo-Jack; Hasan Askari; Gunjan Tykodi; Jianmei Liu; Indira Umamaheswaran
Journal:  Horm Res       Date:  2008-07-29

9.  Effects of chronic central leptin infusion on proopiomelanocortin and neurotensin gene expression in the rat hypothalamus.

Authors:  Abhiram Sahu
Journal:  Neurosci Lett       Date:  2008-05-28       Impact factor: 3.046

Review 10.  [Diabetes mellitus as a complication of treatment with atypical neuroleptics. Possible pathomechanisms and treatment recommendations].

Authors:  H Jahn; T Schneider
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.